ROMO1 and cancer: Mechanistically, too much ROS produced by ROMO1 can stimulate redox-sensitive oncogenic pathways (NF-κB, MAPK/ERK, TGF-β), encourage the change of epithelium to mesenchymal tissue, and stimulate the migration and multiplication of cancer cells [8].